(Q53431081)

14 May 2018

review article

1 reference

title

Progress in understanding the molecular pathogenesis of human lung cancer. (English)

1 reference

14 May 2018

author name string

Y Sekido

series ordinal

1

1 reference

14 May 2018

K M Fong

series ordinal

2

1 reference

14 May 2018

J D Minna

series ordinal

3

1 reference

14 May 2018

publication date

1 August 1998

1 reference

14 May 2018

Biochimica et Biophysica Acta

published in

1 reference

14 May 2018

volume

1378

1 reference

14 May 2018

page(s)

F21-59

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

Involvement of signal transduction pathways in lung cancer biology.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Bombesin receptor structure and expression in human lung carcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Bombesin-like peptides and airway repair: a recapitulation of lung development?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Impaired lung branching morphogenesis in the absence of functional EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Insulin-like growth factor expression in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

The interaction of Ras with GTPase-activating proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Absence of activating mutations of the RAF1 protooncogene in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Mutation analysis of the coding sequences of MEK-1 and MEK-2 genes in human lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

1 reference

7 January 2021

Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Complex intrachromosomal rearrangement in the process of amplification of the L-myc gene in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Expression of oncoproteins in primary human non-small cell lung cancer and incidence of metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Overexpression of oncoproteins in non-small cell lung carcinomas of smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Identification of novel regions of altered DNA copy number in small cell lung tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Expression of bcl-2--protein in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

bcl-2 protein in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Conversion of Bcl-2 to a Bax-like death effector by caspases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Overexpression of Bcl-2 and mutations in p53 and K-ras in resected human non-small cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Bax suppresses tumorigenesis and stimulates apoptosis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Immunocytochemical markers in stage I lung cancer: relevance to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Vascular endothelial growth factor and lymph node metastasis in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Immunohistochemical detection of basic fibroblast growth factor as a prognostic indicator in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Association of p53 protein expression in stage I lung adenocarcinoma with reference to cytological subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Non-small cell lung cancer: clinical value of new biological predictors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Serum p53 antibodies as early markers of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Serum Anti-p53 Antibodies and Prognosis of Patients With Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

p73 is a simian [correction of human] p53-related protein that can induce apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Absence of a mutation of the p21/WAF1 gene in human lung and pancreatic cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Repression of RNA polymerase III transcription by the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Tumor induction and tissue atrophy in mice lacking E2F-1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Non-ocular cancer in relatives of retinoblastoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Frequent loss of the short arm of chromosome 9 in resected non-small-cell lung cancers from Japanese patients and its association with squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4l (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Alterations of CDKN2 (p16) in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Loss of heterozygosity at 9p21 loci and mutations of the MTS1 and MTS2 genes in human lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

p16/CDKN2 gene and p53 gene alterations in Japanese non-smoking female lung adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Mutations and altered expression of p16INK4 in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

A submicroscopic homozygous deletion at the D3S3 locus in a cell line isolated from a small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Characterization of the submicroscopic deletion in the small-cell lung carcinoma (SCLC) cell line U2020

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: a strategy for cloning the putative tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Sequence analysis of a 685-kb genomic region on chromosome 3p22-p21.3 that is homozygously deleted in a lung carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

The FHIT gene 3p14.2 is abnormal in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Replacement of Fhit in cancer cells suppresses tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Protein expression and functional analysis of the FHIT gene in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Mutation of a mutL homolog in hereditary colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Retinoids in lung development.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Retinoic acid receptor expression abnormalities in lung cancer: important clues or major obstacles?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Implication of RARB in epidermoid (Squamous) lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Lung tumors in mice expressing an antisense RARbeta2 transgene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Absence of mutations in the transforming growth factor-beta type II receptor in sporadic lung cancers with microsatellite instability and rare H-ras1 alleles.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Allelic losses in human chromosome 11 in lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Deletion mapping of chromosome 2 in human lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Isolation of DNA sequences deleted in lung cancer by genomic difference cloning

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Mutation analysis of the PTEN/MMAC1 gene in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Microsatellite alterations as clonal markers for the detection of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Microsatellite instability in primary and metastatic lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Microsatellite alterations in plasma DNA of small cell lung cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Microsatellite instability in lung cancer patients 40 years of age or younger

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Rare alleles at different VNTR loci among lung-cancer patients with microsatellite instability in tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Specific association of human telomerase activity with immortal cells and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Telomerase activity in small-cell and non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Human DNA-(Cytosine-5) Methyltransferase-PCNA Complex as a Target for p21WAF1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Altered imprinting in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Cigarettes, sex, and lung adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Cigarette smoking and changes in the histopathology of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Influence of a mutation reducing the catalytic activity of the cytochrome P450 CYP2D6 on lung cancer susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Functional significance of different human CYP1A1 genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme μ

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Familial aggregation of lung cancer among hospital patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Familial risk of lung cancer among nonsmokers and their relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Evidence for mendelian inheritance in the pathogenesis of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Effect of cohort differences in smoking prevalence on models of lung cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Genetic component of lung cancer: cohort study of twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Molecular basis for lack of expression of HLA class I antigens in human small-cell lung carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Stem cells in lung development, disease, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

An achaete-scute homologue essential for neuroendocrine differentiation in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900010-9

7 January 2021

10.1016/S0304-419X(98)00010-9

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

9739759

1 reference

14 May 2018